Partnerships in Pharma

Creative partnerships and business model innovation between pharma companies and non-traditional players are increasingly helping to speed up drug development, reduce costs and meet the increasing demand for personalised healthcare and patient empowerment.

No two relationships are alike and partnerships demand a unique alignment of financial and operational resources. Successful collaborations depend on a multitude of critical factors, all of which will be explored at the Economist Intelligence Unit’s Partnerships in Pharma seminar. This EIU seminar will join expert speakers from across the industry with 100 senior executives to examine the rationale for partnerships at each stage of the value chain and discuss the opportunities they present.

	Iain Scott Senior Editor Economist Intelligence Unit		Kerstin Valinder Executive Vice-president Business Development Nycomed		Martin Dewhurst Director McKinsey & Co
	Philippe Lopes-Fernandes Head of Global Business Development and Alliances Management Merck Serono		Richard Barker Director General Association of the British Pharmaceutical Industry		Dominique Limet Chief Executive Officer Viiv Healthcare
	Sean McKercher Vice-president Corporate Business Development Ipsen		Shaun Grady Vice-president Strategic Partnering and Business Development AstraZeneca		James Eshelby Senior Director, R&D Business Development Pfizer
	Carole Nuechterlein Head of Venture Fund Roche		John Watson Corporate Vice-president and President of Strategic Partnering and Integrated Drug Development Covance